AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 103 filers reported holding AVROBIO INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $322,000 | -32.1% | 83,690 | -1.4% | 0.00% | – |
| Q3 2021 | $474,000 | -29.7% | 84,919 | +12.0% | 0.00% | – |
| Q2 2021 | $674,000 | -25.8% | 75,832 | +6.0% | 0.00% | – |
| Q1 2021 | $908,000 | -32.1% | 71,519 | -25.5% | 0.00% | – |
| Q4 2020 | $1,337,000 | +13.3% | 95,937 | +5.9% | 0.00% | – |
| Q3 2020 | $1,180,000 | -33.6% | 90,630 | -10.9% | 0.00% | -100.0% |
| Q2 2020 | $1,776,000 | -4.9% | 101,757 | -15.2% | 0.00% | 0.0% |
| Q1 2020 | $1,867,000 | -9.7% | 119,994 | +16.9% | 0.00% | 0.0% |
| Q4 2019 | $2,067,000 | +48.6% | 102,645 | +4.2% | 0.00% | 0.0% |
| Q3 2019 | $1,391,000 | +10.0% | 98,496 | +26.6% | 0.00% | 0.0% |
| Q2 2019 | $1,265,000 | -27.4% | 77,788 | -1.6% | 0.00% | 0.0% |
| Q1 2019 | $1,743,000 | +259.4% | 79,036 | +171.6% | 0.00% | – |
| Q4 2018 | $485,000 | – | 29,103 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |